We are a company focused on early detection and prevention of progressive diseases. Our goal is to streamline the diagnostic process; saving lives and reducing the cost of burden

1. The Best Form of Treatment is the Kind that Never has to Happen
Confidential: Internal Use Only
1

2. Who are we?
● We are a Digital Health Startup
Company that is focused on
identifying high-risk individuals
through patient-reported information
and providing proactive, targeted
interventions to improve their health
and reduce the cost burden for all
paying parties.
● https://www.riskaversehealth.com
Provisional Patent Pending, Evidence-Based,
Algorithm Led Risk Reducing Calculator
Upon 1000s of hours of research, our Health Advisory
Platform calculates an individual’s risk for a disease
based on their lifestyle factors
The Core of our Platform
Data Monetization
We have anonymously collected approximately 1,200
datasets to later be used for data repurposing processes
to the insurance/pharma industries
Constant Engagement through our AI Driven Mobile
Application
We engage the individual on a daily basis in order to track
their lifestyle and ensure that necessary actions are taken
to optimally reduce their risk
2

3. The Team
Kaushik Viswanathan
Co-Founder
Michael Lloyd
Co-Founder
Advisory Board
Corbin Petro, MBA
CEO/President of Benevera
Health
Dr. Parul Penkar, MD
Radiologist, MGH
Dr. K. Vish Viswanath, PhD
Dana Farber
Dr. W Scott Melvin, MD
Division Chief, General Surgery
Montefiore Medical Center
● Boston College, Biology 2018
● Multiple years and summer
internships in the cancer research
realm, most recently at Dana
Farber
● Boston College, Biology 2018;
● Over 1000 hours of PT-Based
clinical experience, most recently
at BU
● Modern Healthcare 15 ‘Up and
Comers’ List
● Benevera Health is a well
established Insurance company
partnered with Institutions like
Harvard Pilgrim
● Professor at Harvard School of
Public Health
● Lead Researcher on Lung
Cancer Risk Factors and
Prevention at DCFI
● Internationally recognized for
Cancer-Related Surgeries and
new technology development
● Montefiore is one of the most
established Hospitals in New
York, and a leader in innovation.
● 15 Year Experience and Head
Instructor in Radiology at MGH
● Specializes in Diagnostic
Radiology and has numerous
Connections to Screening
Programs within MGH 3

4. TAM Greater than $100B
4
$3.75
Billion
Lung
Cancer
$61.67
Billion
Diabetes
$7.7
Billion
Coronary Artery
Disease
$4.84
Billion
Colorectal
Cancer
$3.79
Billion
Breast
Cancer
Starting with Lung Cancer, the flaws with current approaches (ex. CDC) to promote early
detection and prevention leave 77.8% of diagnosis at stages III and IV, which costs $100,000
more annually for treatment compared to stage I.

5. 5
Monetization Verticals
Subscription to
Platform
● Customers will be able to
access our engaging
premium platform, which
will provide more features
at a low cost
● Will allow them for more
personalization to help
them turn their
risk-enhancing habitual
lifestyle habits into
risk-reducing habits
● Mobile/wearable device
functionality
Business
Enterprises
● Provide corporations with
superior wellness initiative
program
● Contains both disease
management and lifestyle
management initiatives
via consistent, direct
engagement
● Very competitive base
price with incentive based
bonus structure
Data
● Will repurpose data to
Insurance/Pharma
industries
● Provide cohorts for clinical
trials through database
● Utilize trend analysis of
data to research
institutions
● Limitless potential for
utilizing data!
Product
Partnerships
● Through identifying those
at high-risk, we will
recommend referrals to
the individual to our
partnered product
services.
● We are able to
demographically provide
the nearest organizations
to the individual

6. Product
Partnerships
To show the value of their
risk-reducing products,
product-based companies
will use our platform for
their consumers.
6
Data Responses will Accumulate Through our Established Pipelines
Business
Enterprises
Businesses will utilize our
platform as a superior
wellness initiative
program.
Social Media
Using a market strategy
tailored to the likes of
Facebook and Instagram,
we will promote our
platform to the 2 billion
active users on social
media.
Healthcare
Partnerships
Through utilization of our
platform, patients from our
partnered health groups
will complete the
assessment.
SEO
With a strong SEO, we
will be able to generate
relevant, organic traffic to
the site.
Data Accumulation
Data will be stored in a HIPAA-safe manner. Upon
validation, the stored data will eventually be
anonymously reaggregated in a manner similar to
Flatiron Health

7. The Potential Value of RiskAverse’s Data
Submissions: 1,134
57.1%
Chance of Lung Related
Disease if you DO have
previous history of stroke
29.1%
Chance of Lung Related
Disease if you DO NOT
have previous history of
stroke
vs.
Stroke and Lung Related Diseases
19.2%
Chance of High Exercise
Levels if you DO NOT
HAVE insurance
39.0%
Chance of High Exercise
Levels if you HAVE
insurance
vs.
Insurance and Exercise Levels
7
Cohort Population Density (Percentile Ranks)
0% 20% 40% 60% 80% 100%

8. How is RiskAverse Different?
RiskAverse is the only solution that is based on up-to-date research embedded with real time analytics and strong patient
engagement features
Company
Publication-Based
Risk Calculator
Collect
Direct-From-Patient
Responses
Real Time, Personalized
Interactions
Accessible to the
General Public
AI Powered Machine
Learning
EHR Based Platform
8

9. 9
Growth Plan
Monetization Vertical 2019 2020 2021 2022 2023
Business Enterprises $75,000 $3,000,000 $10,500,000 $18,000,000 $24,000,000
Subscription to Platform $21,390 $141,768 $508,846 $1,826,393 $6,555,500
Product Partnerships $1,550 $15,500 $77,500 $232,500 $620,000
Data $30,000 $300,000 $1,500,000 $4,500,000 $12,000,000

10. Investment Opportunity
$500,000
In Funding
Funding to be Used for:
Integration of AI into platform: $70,000
Hiring of Coders, Researchers, Marketing Analysts: $225,000
HIPAA Compatible Database: $100,000
Development into Phone/Wearable Device Application: $80,000
Transition to AWS: $5,000
Winning the SEO Game: $20,000
10

11. 11
Appendix

12. Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4
# of Businesses
2019 2020 2021 2022
30 400 900 1600
13,250 180,000 850,000 2,500,000# of Datasets
Scale to top 10 Progressive Diseases
Master Health Risk
Assessment (HRA) 2.0
Begin repurposing data to Insurance
and Pharmaceutical Industries
Sell to Business Enterprises/Partner with Healthcare Providers
Proof Points: 1st Disease
Validation
Formulate into Health Application
(Apple Watch/Fitbit Integration)
Continue Scaling
Pre-Seed/Angel Round:
$500,000
Seed Round Series A
Into the Future
Funding
Schedule
Proof Points: All Other Disease Validations
12

13. Medical Expense Reductions
Annual Total
Cost of Care
for Lung
Cancer:
$13.9 Billion
Annual Total
Savings of
Early
Detection:
$3.75 Billion
Early Detection can save
approximately 26.92%
Preventative
Care:
First-Year
Expenses Saved
per Patient:
$240,742.03
Early
Detection:
Amount Saved
Per Patient:
$64,812.50
Complete Prevention of Lung Cancer
Earlier Detection of Lung
Cancer
(i.e. Stage “X” → Stage 1)
13

14. The Problem
We focus on Lung Cancer and plan to expand to other diseases
in the future.
92% of Lung Cancer risk arises from environmental and
lifestyle factors
Approximately 77.8% are detected at Stages III/IV.
Total cost of care increases by approximately $100,327 from
stage I to stage IV.
Earlier detection of Lung Cancer can save $3.75 Billion in
medical expenses.
14

15. RiskAverse vs. Current Approaches
Approximately 50,000 of the 234,100 individuals diagnosed with Lung Cancer annually do not fall into the
criteria for someone who should consider a screening
15

16. How would Susan uses our Platform to Reduce Medical Costs
Step 1 Step 2 Step 3 Step 4 Step 5
She receives her
score, along with all
the risk-reducing
solutions that she
can adjust over time
in an engaging
fashion
Susan is directed to
our platform through
strong SEO or our
white-labelled
product with various
customers/partners,
and takes the quiz
We offer Susan
three types of
solutions:
● Support
Interventions
● Product Referrals
● RiskAverse Initiated
Interventions
On the backend,
Susan’s data is
accumulated in a
HIPAA safe-manner
in our database,
which we later use
for data repurposing
processes
Susan is offered
post-intervention
follow-ups through
engaging marketing
techniques
(auto-call/split up
questions) method
to collect a
longitudinal view of
our data on her
16

17. How do we work (Example: Susan)?
17
Susan takes
the Quiz
Data is stored in
our HIPAA secure
Database
High-Risk
Low Risk
Low Risk
Lung Cancer
Diabetes
Coronary Artery
Disease
Referral?
Susan is directed to one of our
nearby partnered, support
groups (i.e., hospital systems,
CMOs, etc.)Yes
Susan is directed to RiskAverse’s
disease specific, initiated interventions
(i.e., mobile/apple watch engagement
application, etc.) to reduce her risk
After 6-12 months and constant
engagement with Susan, we provide
post-follow-up interventions with our
improved machine-learning platform,
and her results are stored in our
database for a longitudinal viewpoint
No